nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethadione—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.116	0.147	CbGbCtD
Trimethadione—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0856	0.108	CbGbCtD
Trimethadione—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0856	0.108	CbGbCtD
Trimethadione—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0774	0.0978	CbGbCtD
Trimethadione—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0712	0.09	CbGbCtD
Trimethadione—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0712	0.09	CbGbCtD
Trimethadione—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0546	0.0691	CbGbCtD
Trimethadione—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.054	0.0682	CbGbCtD
Trimethadione—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0369	0.0466	CbGbCtD
Trimethadione—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.036	0.0455	CbGbCtD
Trimethadione—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0352	0.0445	CbGbCtD
Trimethadione—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0314	0.0397	CbGbCtD
Trimethadione—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0184	0.0233	CbGbCtD
Trimethadione—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0174	0.022	CbGbCtD
Trimethadione—Personality change—Prednisolone—chronic obstructive pulmonary disease	0.00529	0.0458	CcSEcCtD
Trimethadione—Emotional distress—Salbutamol—chronic obstructive pulmonary disease	0.00416	0.036	CcSEcCtD
Trimethadione—Personality change—Prednisone—chronic obstructive pulmonary disease	0.00385	0.0333	CcSEcCtD
Trimethadione—Albuminuria—Aminophylline—chronic obstructive pulmonary disease	0.0033	0.0286	CcSEcCtD
Trimethadione—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00284	0.0304	CbGpPWpGaD
Trimethadione—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00251	0.0269	CbGpPWpGaD
Trimethadione—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.0021	0.0181	CcSEcCtD
Trimethadione—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00206	0.022	CbGpPWpGaD
Trimethadione—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00189	0.0164	CcSEcCtD
Trimethadione—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00175	0.0187	CbGpPWpGaD
Trimethadione—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00171	0.0148	CcSEcCtD
Trimethadione—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00162	0.0173	CbGpPWpGaD
Trimethadione—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00159	0.017	CbGpPWpGaD
Trimethadione—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00156	0.0167	CbGpPWpGaD
Trimethadione—Lymphadenopathy—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.013	CcSEcCtD
Trimethadione—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.0015	0.013	CcSEcCtD
Trimethadione—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.0126	CcSEcCtD
Trimethadione—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00145	0.0126	CcSEcCtD
Trimethadione—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00142	0.0152	CbGpPWpGaD
Trimethadione—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00142	0.0152	CbGpPWpGaD
Trimethadione—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00136	0.0118	CcSEcCtD
Trimethadione—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00132	0.0141	CbGpPWpGaD
Trimethadione—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00129	0.0138	CbGpPWpGaD
Trimethadione—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00127	0.011	CcSEcCtD
Trimethadione—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00127	0.0136	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—chronic obstructive pulmonary disease	0.00125	0.0133	CbGpPWpGaD
Trimethadione—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.0106	CcSEcCtD
Trimethadione—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.0106	CcSEcCtD
Trimethadione—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.0103	CcSEcCtD
Trimethadione—CYP2E1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00116	0.0124	CbGpPWpGaD
Trimethadione—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00116	0.0124	CbGpPWpGaD
Trimethadione—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.00991	CcSEcCtD
Trimethadione—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00987	CcSEcCtD
Trimethadione—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.00983	CcSEcCtD
Trimethadione—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00113	0.0121	CbGpPWpGaD
Trimethadione—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00946	CcSEcCtD
Trimethadione—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.0094	CcSEcCtD
Trimethadione—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.00933	CcSEcCtD
Trimethadione—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00104	0.0112	CbGpPWpGaD
Trimethadione—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00902	CcSEcCtD
Trimethadione—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00103	0.011	CbGpPWpGaD
Trimethadione—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00103	0.011	CbGpPWpGaD
Trimethadione—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00889	CcSEcCtD
Trimethadione—Hiccups—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00879	CcSEcCtD
Trimethadione—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00857	CcSEcCtD
Trimethadione—CYP2E1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000972	0.0104	CbGpPWpGaD
Trimethadione—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000968	0.00838	CcSEcCtD
Trimethadione—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000945	0.00818	CcSEcCtD
Trimethadione—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000941	0.0101	CbGpPWpGaD
Trimethadione—CYP2E1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000934	0.00998	CbGpPWpGaD
Trimethadione—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000933	0.00808	CcSEcCtD
Trimethadione—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000922	0.00798	CcSEcCtD
Trimethadione—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000893	0.00773	CcSEcCtD
Trimethadione—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000888	0.00769	CcSEcCtD
Trimethadione—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000871	0.00755	CcSEcCtD
Trimethadione—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000844	0.00902	CbGpPWpGaD
Trimethadione—CYP2C8—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00084	0.00897	CbGpPWpGaD
Trimethadione—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000837	0.00725	CcSEcCtD
Trimethadione—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000837	0.00725	CcSEcCtD
Trimethadione—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00083	0.00719	CcSEcCtD
Trimethadione—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00083	0.00718	CcSEcCtD
Trimethadione—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000825	0.00714	CcSEcCtD
Trimethadione—CYP2C8—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000808	0.00863	CbGpPWpGaD
Trimethadione—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.0008	0.00855	CbGpPWpGaD
Trimethadione—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000794	0.00688	CcSEcCtD
Trimethadione—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000782	0.00677	CcSEcCtD
Trimethadione—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000764	0.00661	CcSEcCtD
Trimethadione—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00076	0.00658	CcSEcCtD
Trimethadione—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00076	0.00658	CcSEcCtD
Trimethadione—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00075	0.00801	CbGpPWpGaD
Trimethadione—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000749	0.00649	CcSEcCtD
Trimethadione—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000744	0.00644	CcSEcCtD
Trimethadione—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000739	0.0064	CcSEcCtD
Trimethadione—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000739	0.0064	CcSEcCtD
Trimethadione—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000737	0.00638	CcSEcCtD
Trimethadione—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000721	0.0077	CbGpPWpGaD
Trimethadione—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000718	0.00622	CcSEcCtD
Trimethadione—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000718	0.00621	CcSEcCtD
Trimethadione—CYP2E1—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000706	0.00754	CbGpPWpGaD
Trimethadione—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.00604	CcSEcCtD
Trimethadione—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000695	0.00602	CcSEcCtD
Trimethadione—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000694	0.00601	CcSEcCtD
Trimethadione—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000689	0.00597	CcSEcCtD
Trimethadione—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000689	0.00597	CcSEcCtD
Trimethadione—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000684	0.0073	CbGpPWpGaD
Trimethadione—CYP2E1—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000679	0.00725	CbGpPWpGaD
Trimethadione—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000677	0.00586	CcSEcCtD
Trimethadione—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000657	0.00702	CbGpPWpGaD
Trimethadione—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000655	0.00567	CcSEcCtD
Trimethadione—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.00563	CcSEcCtD
Trimethadione—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000641	0.00555	CcSEcCtD
Trimethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000636	0.00679	CbGpPWpGaD
Trimethadione—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000621	0.00538	CcSEcCtD
Trimethadione—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00062	0.00663	CbGpPWpGaD
Trimethadione—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00061	0.00652	CbGpPWpGaD
Trimethadione—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000605	0.00524	CcSEcCtD
Trimethadione—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000605	0.00524	CcSEcCtD
Trimethadione—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000602	0.00521	CcSEcCtD
Trimethadione—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000594	0.00515	CcSEcCtD
Trimethadione—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000594	0.00515	CcSEcCtD
Trimethadione—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000592	0.00513	CcSEcCtD
Trimethadione—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00509	CcSEcCtD
Trimethadione—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000587	0.00627	CbGpPWpGaD
Trimethadione—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000586	0.00507	CcSEcCtD
Trimethadione—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000582	0.00504	CcSEcCtD
Trimethadione—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000576	0.00499	CcSEcCtD
Trimethadione—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000576	0.00499	CcSEcCtD
Trimethadione—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000571	0.00494	CcSEcCtD
Trimethadione—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000567	0.00491	CcSEcCtD
Trimethadione—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000564	0.00489	CcSEcCtD
Trimethadione—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000561	0.00486	CcSEcCtD
Trimethadione—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000558	0.00484	CcSEcCtD
Trimethadione—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000557	0.00595	CbGpPWpGaD
Trimethadione—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000554	0.0048	CcSEcCtD
Trimethadione—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000553	0.00479	CcSEcCtD
Trimethadione—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000551	0.00477	CcSEcCtD
Trimethadione—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000551	0.00477	CcSEcCtD
Trimethadione—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00055	0.00476	CcSEcCtD
Trimethadione—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00475	CcSEcCtD
Trimethadione—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000547	0.00473	CcSEcCtD
Trimethadione—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000547	0.00473	CcSEcCtD
Trimethadione—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000545	0.00582	CbGpPWpGaD
Trimethadione—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000544	0.00471	CcSEcCtD
Trimethadione—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000539	0.00576	CbGpPWpGaD
Trimethadione—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000535	0.00464	CcSEcCtD
Trimethadione—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000528	0.00458	CcSEcCtD
Trimethadione—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000528	0.00458	CcSEcCtD
Trimethadione—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000527	0.00456	CcSEcCtD
Trimethadione—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000524	0.0056	CbGpPWpGaD
Trimethadione—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000522	0.00452	CcSEcCtD
Trimethadione—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000522	0.00452	CcSEcCtD
Trimethadione—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000522	0.00452	CcSEcCtD
Trimethadione—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00052	0.0045	CcSEcCtD
Trimethadione—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00449	CcSEcCtD
Trimethadione—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000518	0.00448	CcSEcCtD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	0.000517	0.00552	CbGpPWpGaD
Trimethadione—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.00447	CcSEcCtD
Trimethadione—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000512	0.00443	CcSEcCtD
Trimethadione—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000511	0.00442	CcSEcCtD
Trimethadione—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00051	0.00441	CcSEcCtD
Trimethadione—CYP2E1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000499	0.00533	CbGpPWpGaD
Trimethadione—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000499	0.00432	CcSEcCtD
Trimethadione—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000497	0.00531	CbGpPWpGaD
Trimethadione—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000492	0.00426	CcSEcCtD
Trimethadione—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00049	0.00524	CbGpPWpGaD
Trimethadione—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00048	0.00415	CcSEcCtD
Trimethadione—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00048	0.00415	CcSEcCtD
Trimethadione—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000478	0.0051	CbGpPWpGaD
Trimethadione—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000473	0.0041	CcSEcCtD
Trimethadione—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.0041	CcSEcCtD
Trimethadione—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00047	0.00407	CcSEcCtD
Trimethadione—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.00047	0.00502	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	0.000467	0.00499	CbGpPWpGaD
Trimethadione—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00401	CcSEcCtD
Trimethadione—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00392	CcSEcCtD
Trimethadione—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000451	0.00482	CbGpPWpGaD
Trimethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000447	0.00478	CbGpPWpGaD
Trimethadione—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00387	CcSEcCtD
Trimethadione—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000434	0.00463	CbGpPWpGaD
Trimethadione—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000433	0.00375	CcSEcCtD
Trimethadione—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000432	0.00461	CbGpPWpGaD
Trimethadione—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000425	0.00368	CcSEcCtD
Trimethadione—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.00368	CcSEcCtD
Trimethadione—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00365	CcSEcCtD
Trimethadione—Rash—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00365	CcSEcCtD
Trimethadione—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00365	CcSEcCtD
Trimethadione—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00365	CcSEcCtD
Trimethadione—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00363	CcSEcCtD
Trimethadione—Headache—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00363	CcSEcCtD
Trimethadione—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000419	0.00362	CcSEcCtD
Trimethadione—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000416	0.0036	CcSEcCtD
Trimethadione—Rash—Montelukast—chronic obstructive pulmonary disease	0.000413	0.00357	CcSEcCtD
Trimethadione—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000413	0.00441	CbGpPWpGaD
Trimethadione—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00357	CcSEcCtD
Trimethadione—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000412	0.00356	CcSEcCtD
Trimethadione—Headache—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00355	CcSEcCtD
Trimethadione—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000405	0.00432	CbGpPWpGaD
Trimethadione—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.00431	CbGpPWpGaD
Trimethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.00431	CbGpPWpGaD
Trimethadione—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00347	CcSEcCtD
Trimethadione—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.0004	0.00346	CcSEcCtD
Trimethadione—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000399	0.00345	CcSEcCtD
Trimethadione—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000398	0.00425	CbGpPWpGaD
Trimethadione—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000398	0.00345	CcSEcCtD
Trimethadione—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000398	0.00344	CcSEcCtD
Trimethadione—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000397	0.00344	CcSEcCtD
Trimethadione—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000397	0.00344	CcSEcCtD
Trimethadione—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00342	CcSEcCtD
Trimethadione—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000392	0.00418	CbGpPWpGaD
Trimethadione—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000389	0.00337	CcSEcCtD
Trimethadione—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000376	0.00402	CbGpPWpGaD
Trimethadione—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00325	CcSEcCtD
Trimethadione—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000373	0.00323	CcSEcCtD
Trimethadione—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000372	0.00322	CcSEcCtD
Trimethadione—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00037	0.00321	CcSEcCtD
Trimethadione—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000363	0.00387	CbGpPWpGaD
Trimethadione—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00036	0.00385	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000357	0.00381	CbGpPWpGaD
Trimethadione—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000356	0.00381	CbGpPWpGaD
Trimethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000349	0.00373	CbGpPWpGaD
Trimethadione—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000344	0.00368	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.00033	0.00353	CbGpPWpGaD
Trimethadione—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000328	0.00351	CbGpPWpGaD
Trimethadione—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000328	0.0035	CbGpPWpGaD
Trimethadione—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000327	0.00284	CcSEcCtD
Trimethadione—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000327	0.00283	CcSEcCtD
Trimethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000327	0.00349	CbGpPWpGaD
Trimethadione—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.00281	CcSEcCtD
Trimethadione—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000318	0.0034	CbGpPWpGaD
Trimethadione—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000315	0.00337	CbGpPWpGaD
Trimethadione—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000311	0.00333	CbGpPWpGaD
Trimethadione—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000307	0.00328	CbGpPWpGaD
Trimethadione—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000299	0.00259	CcSEcCtD
Trimethadione—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000298	0.00258	CcSEcCtD
Trimethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000295	0.00315	CbGpPWpGaD
Trimethadione—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000293	0.00313	CbGpPWpGaD
Trimethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000293	0.00313	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000292	0.00312	CbGpPWpGaD
Trimethadione—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000291	0.00252	CcSEcCtD
Trimethadione—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00029	0.0031	CbGpPWpGaD
Trimethadione—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00251	CcSEcCtD
Trimethadione—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000289	0.00309	CbGpPWpGaD
Trimethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000284	0.00303	CbGpPWpGaD
Trimethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000283	0.00302	CbGpPWpGaD
Trimethadione—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.00299	CbGpPWpGaD
Trimethadione—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00235	CcSEcCtD
Trimethadione—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000262	0.0028	CbGpPWpGaD
Trimethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000253	0.00271	CbGpPWpGaD
Trimethadione—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000252	0.0027	CbGpPWpGaD
Trimethadione—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00217	CcSEcCtD
Trimethadione—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00025	0.00267	CbGpPWpGaD
Trimethadione—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000239	0.00255	CbGpPWpGaD
Trimethadione—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00206	CcSEcCtD
Trimethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000238	0.00254	CbGpPWpGaD
Trimethadione—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00205	CcSEcCtD
Trimethadione—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000232	0.00247	CbGpPWpGaD
Trimethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00023	0.00246	CbGpPWpGaD
Trimethadione—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00198	CcSEcCtD
Trimethadione—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.00198	CcSEcCtD
Trimethadione—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.00197	CcSEcCtD
Trimethadione—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00196	CcSEcCtD
Trimethadione—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.00196	CcSEcCtD
Trimethadione—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000226	0.00242	CbGpPWpGaD
Trimethadione—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000223	0.00238	CbGpPWpGaD
Trimethadione—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00188	CcSEcCtD
Trimethadione—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00186	CcSEcCtD
Trimethadione—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.00186	CcSEcCtD
Trimethadione—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000209	0.00223	CbGpPWpGaD
Trimethadione—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000208	0.0018	CcSEcCtD
Trimethadione—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000207	0.00221	CbGpPWpGaD
Trimethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000206	0.0022	CbGpPWpGaD
Trimethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000205	0.00219	CbGpPWpGaD
Trimethadione—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000204	0.00217	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000191	0.00205	CbGpPWpGaD
Trimethadione—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00163	CcSEcCtD
Trimethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000187	0.002	CbGpPWpGaD
Trimethadione—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00161	CcSEcCtD
Trimethadione—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000185	0.00197	CbGpPWpGaD
Trimethadione—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000183	0.00196	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000181	0.00194	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000181	0.00193	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000179	0.00191	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000174	0.00186	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000171	0.00183	CbGpPWpGaD
Trimethadione—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000168	0.0018	CbGpPWpGaD
Trimethadione—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00145	CcSEcCtD
Trimethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.00179	CbGpPWpGaD
Trimethadione—Rash—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00144	CcSEcCtD
Trimethadione—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00143	CcSEcCtD
Trimethadione—Headache—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00143	CcSEcCtD
Trimethadione—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000161	0.00172	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000159	0.0017	CbGpPWpGaD
Trimethadione—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00135	CcSEcCtD
Trimethadione—CACNA1G—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000153	0.00163	CbGpPWpGaD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.00162	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00015	0.0016	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000148	0.00158	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000147	0.00157	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000145	0.00155	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000145	0.00155	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000143	0.00153	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000137	0.00146	CbGpPWpGaD
Trimethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00145	CbGpPWpGaD
Trimethadione—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.00143	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.00143	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000133	0.00142	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00141	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000131	0.0014	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000127	0.00136	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00135	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000125	0.00134	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00133	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000124	0.00132	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000123	0.00132	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.00131	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.00129	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000115	0.00123	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000114	0.00121	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000113	0.00121	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000112	0.00119	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00011	0.00118	CbGpPWpGaD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00118	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.00117	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000109	0.00116	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00115	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000103	0.0011	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000103	0.0011	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000102	0.00109	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000102	0.00109	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000101	0.00108	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000101	0.00107	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	9.78e-05	0.00104	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.74e-05	0.00104	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.7e-05	0.00104	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.61e-05	0.00103	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.59e-05	0.00102	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—IL6—chronic obstructive pulmonary disease	9.48e-05	0.00101	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.37e-05	0.001	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.24e-05	0.000987	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	8.97e-05	0.000959	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.88e-05	0.000949	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—EGFR—chronic obstructive pulmonary disease	8.8e-05	0.00094	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	8.78e-05	0.000938	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.76e-05	0.000936	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—TNF—chronic obstructive pulmonary disease	8.38e-05	0.000895	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.06e-05	0.000861	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.95e-05	0.000849	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	7.84e-05	0.000837	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	7.14e-05	0.000763	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—IL6—chronic obstructive pulmonary disease	6.76e-05	0.000723	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.73e-05	0.000719	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.72e-05	0.000718	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.63e-05	0.000708	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	6.54e-05	0.000699	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.26e-05	0.000669	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.18e-05	0.00066	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.09e-05	0.000651	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.08e-05	0.00065	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.86e-05	0.000626	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.81e-05	0.000621	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.78e-05	0.000617	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.77e-05	0.000616	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	5.66e-05	0.000604	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.59e-05	0.000597	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.26e-05	0.000562	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.19e-05	0.000555	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.15e-05	0.00055	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.09e-05	0.000544	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	5.05e-05	0.000539	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.73e-05	0.000506	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.71e-05	0.000503	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.69e-05	0.000502	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.69e-05	0.000501	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.6e-05	0.000492	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.28e-05	0.000457	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.19e-05	0.000448	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.74e-05	0.0004	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.58e-05	0.000382	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.53e-05	0.000378	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.41e-05	0.000364	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.22e-05	0.000345	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.12e-05	0.000334	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.09e-05	0.00033	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.05e-05	0.000326	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.04e-05	0.000324	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.97e-05	0.000317	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.85e-05	0.000304	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.82e-05	0.000302	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.79e-05	0.000298	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.76e-05	0.000295	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.73e-05	0.000291	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.57e-05	0.000274	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.54e-05	0.000272	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.52e-05	0.000269	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.49e-05	0.000266	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.49e-05	0.000266	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.48e-05	0.000265	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.44e-05	0.000261	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.32e-05	0.000248	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.29e-05	0.000245	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.28e-05	0.000243	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.27e-05	0.000242	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.16e-05	0.000231	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.14e-05	0.000229	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.11e-05	0.000226	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.09e-05	0.000223	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.97e-05	0.00021	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.91e-05	0.000204	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.89e-05	0.000201	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.87e-05	0.000199	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.76e-05	0.000188	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.74e-05	0.000186	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.72e-05	0.000184	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.67e-05	0.000178	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.66e-05	0.000177	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.64e-05	0.000175	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.6e-05	0.000171	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.000162	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.00016	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.47e-05	0.000157	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.4e-05	0.00015	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.000147	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.27e-05	0.000136	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.21e-05	0.00013	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.000123	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.13e-05	0.000121	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.13e-05	0.000121	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.08e-05	0.000116	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.000113	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.03e-05	0.00011	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.000107	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	9.87e-06	0.000106	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.81e-06	7.27e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.51e-06	6.96e-05	CbGpPWpGaD
